Unknown

Dataset Information

0

Fluoxetine induces autophagic cell death via eEF2K-AMPK-mTOR-ULK complex axis in triple negative breast cancer.


ABSTRACT: OBJECTIVES:Triple negative breast cancer (TNBC) is a complex and intrinsically aggressive tumour with poor prognosis, and the discovery of targeted small-molecule drugs for TNBC treatment still remains in its infancy. In this study, we aimed to discover a small-molecule agent for TNBC treatment and illuminate its potential mechanisms. MATERIALS AND METHODS:Cell viability was detected by using methylthiazoltetrazolium (MTT) assay. Electron microscopy, GFP-LC3 transfection, monodansylcadaverine staining and apoptosis assay were performed to determine Fluoxetine-induced autophagy and apoptosis. Western blotting and siRNA transfection were carried out to investigate the mechanisms of Fluoxetine-induced autophagy. iTRAQ-based proteomics analysis was used to explore the underlying mechanisms. RESULTS:We have demonstrated that Fluoxetine had remarkable anti-proliferative activities and induced autophagic cell death in MDA-MB-231 and MDA-MB-436 cells. The mechanism for Fluoxetine-induced autophagic cell death was associated with inhibition of eEF2K and activation of AMPK-mTOR-ULK complex axis. Further iTRAQ-based proteomics and network analyses revealed that Fluoxetine-induced mechanism was involved in BIRC6, BNIP1, SNAP29 and Bif-1. CONCLUSIONS:These results demonstrate that Fluoxetine induces apoptosis and autophagic cell death in TNBC, which will hold a promise for the future TNBC therapy.

SUBMITTER: Sun D 

PROVIDER: S-EPMC6528897 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fluoxetine induces autophagic cell death via eEF2K-AMPK-mTOR-ULK complex axis in triple negative breast cancer.

Sun Dejuan D   Zhu Lingjuan L   Zhao Yuqian Y   Jiang Yingnan Y   Chen Lixia L   Yu Yang Y   Ouyang Liang L  

Cell proliferation 20171101 2


<h4>Objectives</h4>Triple negative breast cancer (TNBC) is a complex and intrinsically aggressive tumour with poor prognosis, and the discovery of targeted small-molecule drugs for TNBC treatment still remains in its infancy. In this study, we aimed to discover a small-molecule agent for TNBC treatment and illuminate its potential mechanisms.<h4>Materials and methods</h4>Cell viability was detected by using methylthiazoltetrazolium (MTT) assay. Electron microscopy, GFP-LC3 transfection, monodans  ...[more]

Similar Datasets

| S-EPMC4580411 | biostudies-literature
| S-EPMC7468969 | biostudies-literature
| S-EPMC7291649 | biostudies-literature
| S-EPMC6528917 | biostudies-literature
| S-EPMC5636988 | biostudies-literature
| S-EPMC7000121 | biostudies-literature
| S-EPMC7851402 | biostudies-literature
| S-EPMC6690898 | biostudies-literature
| S-EPMC6067839 | biostudies-other
| S-EPMC5126292 | biostudies-literature